Ethnic Differences in the Effects of COVID on the Substance Use Behavior of Emerging Adults

新冠病毒对新兴成年人药物使用行为影响的种族差异

基本信息

  • 批准号:
    10543465
  • 负责人:
  • 金额:
    $ 70.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT Little is known about the adverse psychosocial impact of COVID-19 on demographic groups that are already facing significant health disparities. Native Hawaiian and other Pacific Islanders (NHOPI), who are indigenous to Hawaii and other Pacific Islands, face significant health disparities, which often get overlooked because of NHOPI being combined with low-risk Asian groups in national studies. Compared with Asians, NHOPI are at markedly higher risk for mortality and morbidity due to cancer and cardiovascular disease. In addition, tobacco and other substance use prevalence among NHOPI is much higher than among Asians. This proposal seeks to examine ethnic differences in substance use behavior before and after the spread of COVID-19 across Asians and NHOPI, with reference to Whites. In addition, we will test a new model that attempts to explain the mechanisms of the potential increase in substance use post-COVID among emerging adults (18-29 year olds). Informed by the theories of stress-coping, self-medication, and emerging adulthood (EA), the central postulate of the model is that post-COVID increases in financial distress, EA stress, perceived discrimination, loneliness/social isolation, COVID-related anxieties, and negative life events result in increased generalized stress and poorer mental health among emerging adults, which in turn results in increased substance use (tobacco, alcohol, marijuana, and illicit drugs). We hypothesize that NHOPI will show higher exposure to post-COVID financial distress, EA stress, COVID-related anxieties, loneliness, and negative life events, which will eventually lead to higher substance use among NHOPI. Our team has access to a cohort of emerging adults (N=2335; 55% women; 45% Asian, 20% NHOPI, 24% White, 11% Other) from Hawaii, originally recruited as part of research focused on tobacco control. Despite the tobacco focus, the study collected extensive data on other substance use behavior, mental health symptomatology, and EA attributes, which may be compared against post-COVID changes. We have collected 4 waves of pre-COVID data from the cohort in 6-month intervals. The 4th wave of data collection was completed in January 2020, approximately two months before the state of Hawaii halted all non-essential activities in response to the pandemic, including tourism, a mainstay of Hawaii’s economy. The decreased tourism and closure of businesses have resulted in Hawaii’s economy being one of the worst affected in the U.S. The current study plans to resume post-COVID data collection from the cohort for additional 6 waves. The first of the 6 waves is about to be launched in February-March 2021—approximately 1 year after the last pre-COVID survey—using institutional funds. The current proposal seeks to continue data collection every 6 month for 5 more waves. Across the 4 waves of pre- COVID data collection, we retained 89% of the baseline sample, almost all of whom have expressed interest for continued participation in the study. In sum, this study is significant for seeking to advance knowledge about the mechanisms of COVID-related health disparities and innovative for testing a new conceptual model.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pallav Pokhrel其他文献

Pallav Pokhrel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pallav Pokhrel', 18)}}的其他基金

Ethnic Differences in the Effects of COVID on the Substance Use Behavior of Emerging Adults
新冠病毒对新兴成年人药物使用行为影响的种族差异
  • 批准号:
    10372861
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
Prospective effects of electronic cigarette marketing on expectancies and behavior
电子烟营销对期望和行为的前瞻性影响
  • 批准号:
    9010375
  • 财政年份:
    2016
  • 资助金额:
    $ 70.1万
  • 项目类别:
Full Project I: Adolescent Tobacco and Areca Nut Use Prevention in Guam
完整项目一:关岛青少年烟草和槟榔使用预防
  • 批准号:
    10490853
  • 财政年份:
    2009
  • 资助金额:
    $ 70.1万
  • 项目类别:
Full Project I: Adolescent Tobacco and Areca Nut Use Prevention in Guam
完整项目一:关岛青少年烟草和槟榔使用预防
  • 批准号:
    10266800
  • 财政年份:
    2009
  • 资助金额:
    $ 70.1万
  • 项目类别:
Full Project I: Adolescent Tobacco and Areca Nut Use Prevention in Guam
完整项目一:关岛青少年烟草和槟榔使用预防
  • 批准号:
    10084112
  • 财政年份:
    2009
  • 资助金额:
    $ 70.1万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 70.1万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了